David Scadden is Director at AGIOS PHARMACEUTICALS, INC. (AGIO). They have made 2 open-market trades across 2 companies since 2018, most recently 2026-06-18.
CIK 0001707715
2 open-market purchases totalling $116K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGIO | SELL · 10b5-1 | 2025-11-12 | 2025-11-14 | $43.84 | $9K | -33.4% | -38.4% | -35.6% |
| AGIO | SELL · 10b5-1 | 2025-10-08 | 2025-10-10 | $41.00 | $8K | +2.8% | +1.9% | -30.7% |
| AGIO | SELL · 10b5-1 | 2025-09-30 | 2025-10-02 | $40.00 | $8K | +0.4% | +0.2% | -32.1% |
| AGIO | SELL · 10b5-1 | 2025-08-27 | 2025-08-29 | $40.00 | $8K | -3.9% | +3.3% | -23.2% |
| AGIO | SELL · 10b5-1 | 2025-07-10 | 2025-07-15 | $40.00 | $56K | +1.8% | -6.6% | +4.1% |
| AGIO | SELL · 10b5-1 | 2024-12-11 | 2024-12-13 | $46.28 | $9K | -11.9% | -12.1% | -20.4% |
| MGTA | BUY | 2018-06-25 | 2018-06-27 | $15.00 | $99K | -10.7% | -0.9% | -16.9% |
| AGIO | BUY | 2018-03-16 | 2018-03-20 | $83.44 | $17K | -11.7% | +5.9% | +14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.